Printer Friendly

MEDAMICUS ANNOUNCES SIGNING OF INVESTMENT AGREEMENT WITH EMPI

 MINNEAPOLIS, Nov. 10 /PRNewswire/ -- MedAmicus, Inc. (NASDAQ-NMS: MEDM) today announced that it signed an investment agreement with Empi, Inc. (NASDAQ-NMS: EMPI), whereby Empi purchased 62,500 shares, or 2.5 percent of the outstanding common stock of MedAmicus, for $250,000 and has received warrants to purchase an additional 62,500 shares over the next five years at $6 per share.
 The agreement provides that Empi will commence market evaluation of the MedAmicus LUMAX(TM) Dual Channel Fiber Optic Cystometry System designed to conduct diagnostic screening for urinary incontinence. Upon the successful completion of such market evaluation, the companies would then finalize a 10-year exclusive distribution relationship for the LUMAX incontinence diagnostic system and a one year non-exclusive distribution agreement for the company's fiber optic interface system which allows existing urodynamic pressure monitoring systems to become fiber optic compatible.
 When the companies finalize the LUMAX distribution agreement, Empi will invest an additional $500,000 in MedAmicus stock at a per share price equal to the lesser of 90 percent of the bid price on the date of purchase or $5.40. In addition, Empi would prepay certain purchases of LUMAX product during the first two years of the distribution agreement.
 The company also announced that it is negotiating non-exclusive distribution relationships with other urodynamic testing companies related to its fiber optic interface system. Shipments of the product are expected to commence in the second quarter of 1994.
 "We are enthusiastic about this relationship with Empi and the shared commitment that we both have in addressing the rapidly expanding market for the diagnosis and treatment of incontinence," said Richard Little, MedAmicus president. "The vast number of people who suffer from incontinence and the increasing interest of physicians in treating the condition requires the attention of a large dedicated sales force such as Empi's."
 MedAmicus, Inc., is a Plymouth, Minn.-based medical products company engaged in the design, development, manufacture and marketing of disposable vascular access and pressure monitoring devices. The company's shares are traded on the NASDAQ National Market System under the symbol MEDM.
 -0- 11/10/93
 /CONTACT: James Hartman of MedAmicus, 612-559-2613/
 (MEDM EMPI)


CO: MedAmicus, Inc.; Empi, Inc. ST: Minnesota IN: MTC SU:

CP-AL -- MN006 -- 2651 11/10/93 09:58 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 10, 1993
Words:374
Previous Article:DIGI INTERNATIONAL SUBSIDIARY RECEIVES TENNESSEE QUALITY AWARD
Next Article:THERMO CARDIOSYSTEMS HEART-ASSIST DEVICE TO UNDERGO FDA PANEL REVIEW
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters